Levodopa/Carbidopa/Entacapone Eg

Levodopa/Carbidopa/Entacapone, the active ingredient in Levodopa/Carbidopa/Entacapone Eg, is an Antiparkinson agent presented as an oral tablet for oral use. It is indicated for the management of Parkinson's disease, helping to restore dopamine levels in the brain and improve motor function in adult patients.

GNH USA supplies Levodopa/Carbidopa/Entacapone Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable global logistics.

Levodopa/Carbidopa/Entacapone is used in the Parkinson's disease therapeutic pathway to improve dopaminergic control. - Parkinson's disease: improves overall motor symptoms and reduces rigidity and bradykinesia. - Parkinson's disease with motor fluctuations: decreases OFF time and smooths dopamine delivery. - Early‑stage Parkinson's disease: delays the need for higher levodopa doses and supports sustained symptom control. - Parkinson's disease with dyskinesia: balances levodopa levels to lessen dyskinesia severity. - Parkinson's disease requiring combination therapy: provides a multi‑mechanistic approach for enhanced efficacy.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: feeling of stomach upset that may lead to vomiting. - Dizziness: light‑headedness, especially when standing quickly. - Orthostatic hypotension: drop in blood pressure upon standing. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Hallucinations: visual or auditory disturbances that can affect perception. - Severe dyskinesia: uncontrolled involuntary movements that may be disabling. - Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and muscle rigidity.

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should observe several precautionary measures to ensure patient safety. - Monitor blood pressure: watch for orthostatic changes, especially in the elderly. - Assess psychiatric status: be vigilant for hallucinations or confusion. - Evaluate renal function: adjust therapy if significant impairment is present. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Store at room temperature: keep in the original pack, protect from moisture.

Levodopa/Carbidopa/Entacapone interacts with several drug classes; awareness of these interactions helps optimize therapy.

Major Interactions (Avoid): - MAO‑B inhibitors: risk of hypertensive crisis. - Non‑selective MAO inhibitors: may cause severe hypertension. - Anticholinergics: can mask Parkinsonian symptoms. - Ipecac syrup: increases nausea risk.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect. - SSRIs/SNRIs: potential for serotonin syndrome. - Iron supplements: reduce levodopa absorption; separate dosing by at least two hours.